BEYOND THE BETES: FLOZINS IN FAILURE

December 12, 2022
  • SGLT2 Inhibitors in Heart Failure and Chronic Kidney Disease

Target Audience

  • Pharmacist

Learning Objectives

  • Compare and contrast characteristics of different SGLT2 inhibitors.
  • Evaluate how recent SGLT2 inhibitor literature in patients with HFrEF, HFmrEF, HFpEF and CKD led to inclusion of this medication into both the AHA and KDIGO guidelines
  • Recognize why patients without concomitant type II diabetes may still benefit from inclusion of a SGLT2 inhibitor using recent literature
  • Review guidelines from the AHA and KDIGO detailing their recommendations on SGLT2 inhibitor use in patients with HF and CKD.
  • Identify patients with HF or CKD that would benefit from inclusion of a SGLT2 inhibitor in their treatment plan.
Course summary
Available credit: 
  • 1.00 ACPE - Pharmacist
  • 1.00 Attendance
Registration Opens: 
12/12/2022
Registration Expires: 
12/12/2023
Activity Starts: 
12/12/2022 - 2:30pm EST
Activity Ends: 
12/12/2022 - 3:30pm EST
Add to calendar: 
Rating: 
0
Durham, NC 27705
United States
  • David Scott: 

            Speaker

ACPE-Pharmacist

Available Credit

  • 1.00 ACPE - Pharmacist
  • 1.00 Attendance
Please login or register to take this course.